Clinical Trials Directory

Trials / Completed

CompletedNCT00006203

Naltrexone, Craving, and Drinking

Naltrexone, Craving, and Drinking: Ecological Assessment

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
180 (actual)
Sponsor
Brown University · Academic / Other
Sex
All
Age
21 Years
Healthy volunteers
Not accepted

Summary

This 5-week study will examine the effects of naltrexone on alcohol craving, drinking rates, and reaction to drinking-related triggers, or cues, in participants' everyday environment and in laboratory sessions. Participants will monitor and record their daily desires to drink, environmental circumstances in which urges occur, and drinking behavior using a palm top computer. Participants will receive naltrexone or a placebo. One week after receiving medication, all participants will be asked to respond to alcohol-related cues that may or may not arouse the desire to drink.

Conditions

Interventions

TypeNameDescription
DRUGNaltrexone 50 MgDaily 50 mg for 3 weeks
DRUGPlaceboDaily doses of placebo for 3 weeks

Timeline

Completion
2005-05-01
First posted
2000-09-12
Last updated
2025-06-13

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00006203. Inclusion in this directory is not an endorsement.